HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,191 | -68.0% | 19,603 | -53.1% | 0.00% | – |
Q1 2023 | $63,052 | -39.6% | 41,756 | 0.0% | 0.00% | – |
Q4 2022 | $104,390 | -40.9% | 41,756 | -0.3% | 0.00% | – |
Q3 2022 | $176,763 | +46.8% | 41,887 | -2.9% | 0.00% | – |
Q2 2022 | $120,386 | -46.9% | 43,149 | +9.0% | 0.00% | – |
Q1 2022 | $226,512 | -49.4% | 39,600 | -19.4% | 0.00% | – |
Q4 2021 | $448,000 | -14.3% | 49,117 | +0.4% | 0.00% | – |
Q3 2021 | $523,000 | -35.7% | 48,936 | -6.6% | 0.00% | -100.0% |
Q2 2021 | $813,000 | +2.3% | 52,415 | +6.9% | 0.00% | 0.0% |
Q1 2021 | $795,000 | -26.9% | 49,038 | -4.6% | 0.00% | 0.0% |
Q4 2020 | $1,088,000 | +48.2% | 51,408 | +3.8% | 0.00% | 0.0% |
Q3 2020 | $734,000 | +2.1% | 49,509 | -1.9% | 0.00% | 0.0% |
Q2 2020 | $719,000 | +19.0% | 50,446 | -2.0% | 0.00% | 0.0% |
Q1 2020 | $604,000 | -39.7% | 51,462 | +20.8% | 0.00% | 0.0% |
Q4 2019 | $1,001,000 | +15.7% | 42,592 | -3.5% | 0.00% | 0.0% |
Q3 2019 | $865,000 | +5.2% | 44,135 | -0.2% | 0.00% | 0.0% |
Q2 2019 | $822,000 | -22.0% | 44,222 | +2.5% | 0.00% | 0.0% |
Q1 2019 | $1,054,000 | -3.9% | 43,129 | +2.0% | 0.00% | 0.0% |
Q4 2018 | $1,097,000 | -19.4% | 42,292 | -1.6% | 0.00% | 0.0% |
Q3 2018 | $1,361,000 | -22.8% | 42,997 | -5.3% | 0.00% | -50.0% |
Q2 2018 | $1,763,000 | +63.8% | 45,387 | +16.5% | 0.00% | +100.0% |
Q1 2018 | $1,076,000 | +77.0% | 38,968 | +15.9% | 0.00% | 0.0% |
Q4 2017 | $608,000 | +9.9% | 33,619 | -1.6% | 0.00% | 0.0% |
Q3 2017 | $553,000 | +14.7% | 34,178 | -1.6% | 0.00% | 0.0% |
Q2 2017 | $482,000 | +20.8% | 34,741 | +30.6% | 0.00% | 0.0% |
Q1 2017 | $399,000 | +41.5% | 26,606 | +23.7% | 0.00% | – |
Q4 2016 | $282,000 | -22.3% | 21,508 | +2.1% | 0.00% | -100.0% |
Q3 2016 | $363,000 | -4.7% | 21,067 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $381,000 | +6.1% | 21,104 | +14.0% | 0.00% | – |
Q1 2016 | $359,000 | -26.0% | 18,519 | +2.0% | 0.00% | – |
Q4 2015 | $485,000 | +10.7% | 18,151 | +1.1% | 0.00% | – |
Q3 2015 | $438,000 | -6.8% | 17,952 | +19.0% | 0.00% | -100.0% |
Q2 2015 | $470,000 | +106.1% | 15,087 | -3.9% | 0.00% | – |
Q1 2015 | $228,000 | +39.9% | 15,697 | -3.2% | 0.00% | – |
Q4 2014 | $163,000 | +23.5% | 16,208 | +2.3% | 0.00% | – |
Q3 2014 | $132,000 | -20.5% | 15,846 | +17.9% | 0.00% | – |
Q2 2014 | $166,000 | – | 13,439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |